Mental Health News and Research

Latest Mental Health News and Research

TRIL Centre announces Falls Awareness Day on Oct. 4

The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.

28 Sep 2012

Link between work-family conflict and musculoskeletal pain among nurses

Nurses and other hospital workers, especially those who work long hours or the night shift, often report trying to juggle the demands of the job and family obligations. A study out today by The George Washington University School of Public Health and Health Services (SPHHS) suggests that the higher the work-family conflict the greater the risk that health care workers will suffer from neck and other types of musculoskeletal pain.

28 Sep 2012

Fear hard to extinguish from the teenage brain

A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by a threat, the ability to suppress an emotional response to the threat is diminished which may explain the peak in anxiety and stress-related disorders during this developmental period.

28 Sep 2012

BioLineRx’s BL-1020 safe and effective in treating schizophrenia

BioLineRx, a biopharmaceutical development company, announced today the publication of results from the Phase II EAGLE clinical trial for BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia, showing that BL-1020 is safe and effective in improving schizophrenia, in addition to improving cognitive impairment associated with this condition.

28 Sep 2012

Efavirenz drug may play a key role in brain damage

The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests.

28 Sep 2012

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

28 Sep 2012

AACAP announces new Practice Parameter on issues related to LGBT

The American Academy of Child and Adolescent Psychiatry (AACAP) is proud to announce its new Practice Parameter on issues related to and affecting gay, lesbian, bisexual, and gender variant youth.

27 Sep 2012

First Edition: September 27, 2012

Today's headlines include reports about how the health law and Medicare are buzz words in public opinion polls and on the campaign trail.

27 Sep 2012

Anxiety, depression and insomnia drugs and risk of driving accident: an interview with Hui-Ju Tsai

Anxiety, depression and insomnia drugs have been commonly used to treat mental and emotional disorders, or improve sleep-related problems.

27 Sep 2012

Poor emotion recognition in patients at risk for schizophrenia

Individuals at risk for schizophrenia show significant deficits in facial affect recognition compared with mentally healthy individuals, researchers report.

27 Sep 2012

CJD presents major diagnostic problems

Most patients with sporadic Creutzfeldt-Jakob disease are initially misdiagnosed, with most not receiving a correct diagnosis until they are two-thirds of the way through their disease course, show findings in the Archives of Neurology.

27 Sep 2012

Nottingham expert to study impact of gluten intolerance on patients in the UK

A University of Nottingham expert has been awarded -80,000 by two national charities to study the impact of gluten intolerance on patients in the UK.

27 Sep 2012

Medicaid: Ark. Gov. pushes expansion, Maine hunts for savings

Arkansas's governor is trying to use the health law's Medicaid coverage expansion to prevent a GOP takeover of the state legislature, while Maine hunts for savings in its Medicaid program.

27 Sep 2012

NYU Langone creates new groundbreaking collaboration in autism research

NYU Langone Medical Center announced today the creation of a new groundbreaking collaboration in autism research. The Autism Brain Imaging Data Exchange (ABIDE) is a database of brain scans from more than 15 leading international research institutions and academic medical centers.

27 Sep 2012

Forest submits levomilnacipran NDA with FDA for treatment of major depressive disorder

Forest Laboratories, Inc. and Pierre Fabre Laboratories todayannounced that Forest has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for levomilnacipran, a serotonin norepinephrine reuptake inhibitor (SNRI) for the treatment of Major Depressive Disorder (MDD) in adults.

27 Sep 2012

Infants with regulatory behaviors or maternal psychiatric problems may have increased risk of FSS

Functional somatic symptoms (FSS) are physical complaints, such as headaches, pain, fatigue, and dizziness, that cannot be explained medically. These symptoms affect 10-30% of children and adolescents and account for 2-4% of all pediatric doctor visits.

27 Sep 2012